Procept BioRobotics Corp [PRCT] short interest falls, dropping by 6.79 million million shares

Anna Perez

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Procept BioRobotics Corp shares valued at $785,138 were purchased by MOLL FREDERIC H on Aug 13 ’25. At $39.26 per share, MOLL FREDERIC H acquired 20,000 shares. The insider’s holdings grew to 863,159 shares worth approximately $30.82 million following the completion of this transaction.

Also, Desai Antal Rohit sold 25,000 shares, netting a total of over 1,597,711 in proceeds. Following the sale of shares at $63.91 each, the insider now holds 64,363 shares.

Before that, Desai Antal Rohit had sold 25,000 shares from its account. In a trade valued at $1,584,525, the Director traded Procept BioRobotics Corp shares for $63.38 each. Upon closing the transaction, the insider’s holdings decreased to 25,000 shares, worth approximately $1.41 million.

As published in a research note from BofA Securities on December 08, 2025, Procept BioRobotics Corp [PRCT] has been rated down from a Buy to a Neutral and the price target has been revised to $38. Analysts at Oppenheimer upgraded the stock from ‘”a Perform”‘ to ‘”an Outperform”‘ outlook in a report released in early September. As of July 09, 2025, Stephens has initiated its “an Overweight” rating for PRCT. Earlier on July 07, 2025, Oppenheimer initiated its rating. Their recommendation was “a Perform” for PRCT stock.

Analyzing PRCT Stock Performance

On last trading session, Procept BioRobotics Corp [NASDAQ: PRCT] rose 2.03% to $35.71. The stock’s lowest price that day was $34.8, but it reached a high of $35.85 in the same session. During the last five days, there has been a surge of approximately 7.63%. Over the course of the year, Procept BioRobotics Corp shares have dropped approximately -62.35%. Shares of the company reached a 52-week high of $89.49 on 01/06/25 and a 52-week low of $27.80 on 11/21/25.

Support And Resistance Levels for Procept BioRobotics Corp (PRCT)

According to the 24-hour chart, there is a support level at 35.02, which, if violated, would cause prices to drop to 34.33. In the upper region, resistance lies at 36.13. The next price resistance is at 36.54. RSI (Relative Strength Index) is 60.55 on the 14-day chart, showing neutral technical sentiment.

Is Procept BioRobotics Corp subject to short interest?

Stocks of Procept BioRobotics Corp saw a sharp steep in short interest on 2025-11-28 dropping by -0.82 million shares to 6.79 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 7.61 million shares. A decline of -12.12% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.06 of the overall float, the days-to-cover ratio (short ratio) decline to 4.06.

Which companies own the most shares of Procept BioRobotics Corp (PRCT)?

In terms of Procept BioRobotics Corp share price expectations, FactSet research, analysts set an average price target of 51 in the next 12 months, up nearly 45.71% from the previous closing price of $35.0. Analysts anticipate Procept BioRobotics Corp stock to reach 60 by 2025, with the lowest price target being 50. In spite of this, 2 analysts ranked Procept BioRobotics Corp stock as Buy at the end of 2025. On December 02, 2024, Morgan Stanley assigned a price target of “an Overweight” to the stock and initiated coverage with a $105.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.